162 related articles for article (PubMed ID: 21346400)
21. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil.
Padois K; Cantiéni C; Bertholle V; Bardel C; Pirot F; Falson F
Int J Pharm; 2011 Sep; 416(1):300-4. PubMed ID: 21704140
[TBL] [Abstract][Full Text] [Related]
22. Penetration and release studies of positively and negatively charged nanoemulsions--is there a benefit of the positive charge?
Baspinar Y; Borchert HH
Int J Pharm; 2012 Jul; 430(1-2):247-52. PubMed ID: 22486953
[TBL] [Abstract][Full Text] [Related]
23. Preparation and in vivo evaluation of solid lipid nanoparticles of griseofulvin for dermal use.
Aggarwal N; Goindi S
J Biomed Nanotechnol; 2013 Apr; 9(4):564-76. PubMed ID: 23621015
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study.
Naldi L; Yawalkar N; Kaszuba A; Ortonne JP; Morelli P; Rovati S; Mautone G
Am J Clin Dermatol; 2011 Jun; 12(3):191-201. PubMed ID: 21284407
[TBL] [Abstract][Full Text] [Related]
25. Going skin deep: A direct comparison of penetration potential of lipid-based nanovesicles on the isolated perfused human skin flap model.
Ternullo S; de Weerd L; Holsæter AM; Flaten GE; Škalko-Basnet N
Eur J Pharm Biopharm; 2017 Dec; 121():14-23. PubMed ID: 28916504
[TBL] [Abstract][Full Text] [Related]
26. Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution.
Kang JH; Chon J; Kim YI; Lee HJ; Oh DW; Lee HG; Han CS; Kim DW; Park CW
Int J Nanomedicine; 2019; 14():5381-5396. PubMed ID: 31409994
[No Abstract] [Full Text] [Related]
27. Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles.
Jensen LB; Magnussson E; Gunnarsson L; Vermehren C; Nielsen HM; Petersson K
Int J Pharm; 2010 May; 390(1):53-60. PubMed ID: 19836439
[TBL] [Abstract][Full Text] [Related]
28. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
Pradhan M; Singh D; Singh MR
Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290
[TBL] [Abstract][Full Text] [Related]
29. Solid lipid nanoparticles bearing oxybenzone: in-vitro and in-vivo evaluation.
Gulbake A; Jain A; Khare P; Jain SK
J Microencapsul; 2010 May; 27(3):226-33. PubMed ID: 19622017
[TBL] [Abstract][Full Text] [Related]
30. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
[TBL] [Abstract][Full Text] [Related]
31. Solid lipid nanoparticles for topical administration of Kaempferia parviflora extracts.
Sutthanut K; Lu X; Jay M; Sripanidkulchai B
J Biomed Nanotechnol; 2009 Apr; 5(2):224-32. PubMed ID: 20055101
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential.
Ferreira M; Silva E; Barreiros L; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2016 Oct; 512(1):14-21. PubMed ID: 27530292
[TBL] [Abstract][Full Text] [Related]
33. Lipid nanoparticles for improved topical application of drugs for skin diseases.
Schäfer-Korting M; Mehnert W; Korting HC
Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165
[TBL] [Abstract][Full Text] [Related]
34. Influence of nanocarrier type and size on skin delivery of hydrophilic agents.
Küchler S; Abdel-Mottaleb M; Lamprecht A; Radowski MR; Haag R; Schäfer-Korting M
Int J Pharm; 2009 Jul; 377(1-2):169-72. PubMed ID: 19439166
[TBL] [Abstract][Full Text] [Related]
35. Topical corticosteroid delivery into human skin using hydrofluoroalkane metered dose aerosol sprays.
Reid ML; Benaouda F; Khengar R; Jones SA; Brown MB
Int J Pharm; 2013 Aug; 452(1-2):157-65. PubMed ID: 23684656
[TBL] [Abstract][Full Text] [Related]
36. Nanoencapsulation of betamethasone valerate using high pressure homogenization-solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting.
Md S; Kuldeep Singh JKA; Waqas M; Pandey M; Choudhury H; Habib H; Hussain F; Hussain Z
Drug Dev Ind Pharm; 2019 Feb; 45(2):323-332. PubMed ID: 30404554
[TBL] [Abstract][Full Text] [Related]
37. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
38. Skin Transport of Hydrophilic Compound-Loaded PEGylated Lipid Nanocarriers: Comparative Study of Liposomes, Niosomes, and Solid Lipid Nanoparticles.
Rangsimawong W; Opanasopit P; Rojanarata T; Duangjit S; Ngawhirunpat T
Biol Pharm Bull; 2016; 39(8):1254-62. PubMed ID: 27476936
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles.
Varshosaz J; Minayian M; Moazen E
J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503
[TBL] [Abstract][Full Text] [Related]
40. Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies.
Farboud ES; Nasrollahi SA; Tabbakhi Z
Int J Nanomedicine; 2011; 6():611-7. PubMed ID: 21674018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
